![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Intelence and prezista Once A Day Study (INROADS): A Multicenter, Single-Arm, Open-Label Study of Once Daily Combination of Etravirine (ETR) and Darunavir/Ritonavir (DRV/r) as Dual Therapy in Early Treatment-Experienced Subjects
|
|
|
Reported by Jules Levin
IAS 2013 June 30-July 3 Kuala Lumpur
Peter Ruane,1 Cynthia Brinson,2 Princy Kumar,3 Edwin DeJesus,4 Robert Ryan,5 Michelle Cho,6 David Anderson6
1Peter J Ruane MD Inc., Los Angeles, California, USA; 2Central Texas Clinical Research, Austin, Texas, USA; 3Georgetown University School of Medicine, Washington, DC, USA; 4Orlando Immunology Center, Orlando, Florida, USA; 5Janssen Research & Development, Titusville, New Jersey, USA; 6Janssen Services, LLC, Titusville, New Jersey, USA
![IAS1.gif](../images/071113/071713-4/IAS1.gif)
![IAS2.gif](../images/071113/071713-4/IAS2.gif)
![IAS3.gif](../images/071113/071713-4/IAS3.gif)
![IAS4.gif](../images/071113/071713-4/IAS4.gif)
![IAS5.gif](../images/071113/071713-4/IAS5.gif)
![IAS6.gif](../images/071113/071713-4/IAS6.gif)
![IAS7.gif](../images/071113/071713-4/IAS7.gif)
![IAS8.gif](../images/071113/071713-4/IAS8.gif)
![IAS9.gif](../images/071113/071713-4/IAS9.gif)
![IAS10.gif](../images/071113/071713-4/IAS10.gif)
![IAS11.gif](../images/071113/071713-4/IAS11.gif)
![IAS12.gif](../images/071113/071713-4/IAS12.gif)
![IAS13.gif](../images/071113/071713-4/IAS13.gif)
![IAS14.gif](../images/071113/071713-4/IAS14.gif)
![IAS15.gif](../images/071113/071713-4/IAS15.gif)
![IAS16.gif](../images/071113/071713-4/IAS16.gif)
![IAS17.gif](../images/071113/071713-4/IAS17.gif)
![IAS18.gif](../images/071113/071713-4/IAS18.gif)
![IAS19.gif](../images/071113/071713-4/IAS19.gif)
![IAS20.gif](../images/071113/071713-4/IAS20.gif)
![IAS21.gif](../images/071113/071713-4/IAS21.gif)
![IAS22.gif](../images/071113/071713-4/IAS22.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|